Company Overview

Update
Founded:
December, 2007
Founders:
Charles Magness
Headquarters:
Seattle, WA
Funding:
$9.8M
Categories:
Biotechnology
Description:
Kineta, a biotechnology company, aims at developing leading edge therapeutics in autoimmune disease, viral disease and chronic pain areas.

Detailed Description

Update

Kineta, Inc., a biotechnology company, engages in the discovery and development of antiviral therapies and immune modulating drugs for the treatment of RNA viruses that include hepatitis C, influenza, west nile virus, and common cold. It offers ShK Analogs for treatment of multiple sclerosis and autoimmune diseases; and RIG-I Pathway, a molecular on/off switch that triggers the human body's immune defenses against virus infection. Kineta, Inc. was formerly known as Lecura, Inc. The company was founded in 2007 and is based in Seattle, Washington.

Current Team (4)

Update

Funding Rounds (6) - $9.8M

Update

Investors (1)

Update
  • 8671a1a589075bc942c39bc5ec4322df

    angelMD

    Crowdfunding for Medical Startups

Offices/Locations (1)

Update
  • Main office

    219 Terry Ave N

    Suite 300

    Seattle, WA 98109-5208

    USA